Evidence map›Paper›PMID 21709146›Full record

ArticleAnesthesia and analgesia2011

Enhanced analgesic responses after preferential delivery of morphine and fentanyl to the olfactory epithelium in rats.

John D Hoekman, Rodney J Y Ho

Abstract readComparative Study
In one paragraph

Article in Anesthesia and analgesia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Olfactory Drug Delivery in Rodents: Deposition and Pharmacokinetics.ACS pharmacology & translational science · 2025
    Article
  4. Preparation and Evaluation of theCurrent drug delivery · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Intranasal delivery of a peptide with antidepressant-like effect.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  19. Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

John D HoekmanDepartment of Pharmaceutics, University of Washington, 1959 NE Pacific St. HSB H272, Seattle, WA 98195, USA.
Rodney J Y Ho
Seattle Pacific University · US

Funding

pH Responsive anti-HIV NanoparticlesR01AI077390 · NIAID · UNIVERSITY OF WASHINGTON · PI HO, RODNEY J.Y. · 2009 to 2013
$3.9M
CNS targeted delivery of anti-HIV drugsR43MH086351 · NIMH · IMPEL NEUROPHARMA, INC. · PI HOEKMAN, JOHN · 2009 to 2010
$495k
NIAID NIH HHS AI 077390NIAID NIH HHS R01 AI077390NIMH NIH HHS MH086351NIMH NIH HHS R43 MH086351
6 · The paper itself

Abstract

backgroundCentrally acting opioid analgesics such as morphine and fentanyl are effective, but their efficacy is often limited by a delayed response or side effects resulting from systemic first pass before reaching the brain and the central nervous system (CNS). It is generally accepted that drugs applied to the nasal cavity can directly access the brain and the CNS, which could provide therapeutic advantages such as rapid onset and lower systemic exposure. The olfactory region of the nasal cavity has been implicated in facilitating this direct nose-to-CNS transfer. If the fraction of opioid administered to the olfactory region could be improved, there could be a larger fraction of drug directly delivered to the CNS, mediating greater therapeutic benefit.

methodsWe have developed a pressurized olfactory delivery (POD) device to consistently and noninvasively deposit a majority of drug on the olfactory region of the nasal cavity in Sprague-Dawley rats. Using the tail-flick latency test and analysis of plasma and CNS tissue drug exposure, we compared distribution and efficacy of the opioids morphine and fentanyl administered to the nasal olfactory region with the POD device or the nasal respiratory region with nose drops or systemically via intraperitoneal injection.

resultsCompared with nose drop administration, POD administration of morphine resulted in a significantly higher overall therapeutic effect (area under the curve [over the time course] [AUC](effect)) without a significant increase in plasma drug exposure (AUC(plasma)). POD of morphine resulted in a nose-to-CNS direct transport percentage of 38% to 55%. POD of fentanyl led to a faster (5 vs 10 minutes) and more intense analgesic effect compared with nasal respiratory administration. Unlike intraperitoneal injection or nose drop administration, both morphine and fentanyl given by the POD device to olfactory nasal epithelium exhibited clockwise (plasma) versus effect hysteresis after nasal POD administration, consistent with a direct nose-to-CNS drug transport mechanism.

conclusionsDeposition of opioids to the olfactory region within the nasal cavity could have a significant impact on drug distribution and pharmacodynamic effect, and thus should be considered in future nasally administered opioid studies.

Indexed as

Administration, IntranasalAnalgesics, OpioidAnalysis of VarianceAnimalsCentral Nervous SystemDisease Models, AnimalDose-Response Relationship, DrugDrug Delivery SystemsFentanylInjections, IntraperitonealMaleModels, BiologicalMorphineOlfactory MucosaPainPain MeasurementAnalgesics, OpioidFentanylMorphine

Identifiers

PMID21709146
PMCPMC3161132
OpenAlexW2051455837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.